H.R. 4128 118th Congress
Payment Choice Act of 2023
- Finance and Financial Sector
- Sponsor: Rep. Payne, Donald M. [D-NJ-10]
- Congress.gov ↗
Latest action, May 7, 2024: ASSUMING FIRST SPONSORSHIP - Mr. Rose asked unanimous consent that he may hereafter be considered as the first sponsor of H.R. 4128, a bill originally introduced by Representative Payne, for the purpose of adding cosponsors and requesting reprintings pursuant to clause 7 of rule XII. Agreed to without objection.
How the Senate voted
The Senate hasn't taken a roll call on this bill in the Congresses covered.
17 cosponsors
Sponsored by Rep. Payne, Donald M. [D-NJ-10] (Democrat). Cosponsors by party, House members included:
- Democrats
- Republicans
- Independents
Referred to: House: Financial Services Committee
Who lobbied on it
Clients whose quarterly lobbying reports named it, each quarter.
The clients with the most reports naming it. A report's amount covers all of that client's lobbying in the quarter, not just this bill.
All 25 of 26 clients
| Client | Lobbying firm | Reports | Reports totaling | From | To | Senate |
|---|---|---|---|---|---|---|
| EXACT SCIENCES | 8 | $3.2M | Q1 2023 | Q3 2024 | yes | |
| INFECTIOUS DISEASES SOCIETY OF AMERICA | 8 | $1.6M | Q1 2023 | Q3 2024 | yes | |
| LIFE SCIENCES PENNSYLVANIA | 8 | $29K | Q1 2023 | Q3 2024 | yes | |
| INFIN, A FINANCIAL SERVICES ALLIANCE (F/K/A FINANCIAL SERVICE CENTERS AMERICA) | HUDSON COOK, LLP | 7 | $350K | Q4 2023 | Q3 2024 | yes |
| ABBOTT LABORATORIES | W STRATEGIES, LLC | 6 | $0 | Q4 2023 | Q3 2024 | yes |
| NATIONAL ARMORED CAR ASSOCIATION | ULMAN PUBLIC POLICY & FEDERAL RELATIONS | 4 | $40K | Q1 2024 | Q3 2024 | yes |
| NCR ATLEOS | 4 | $270K | Q1 2024 | Q3 2024 | yes | |
| NCR ATLEOS | CASSIDY & ASSOCIATES, INC. | 4 | $0 | Q1 2024 | Q3 2024 | yes |
| NCR ATLEOS | TROUTMAN STRATEGIES | 4 | $0 | Q1 2024 | Q3 2024 | yes |
| KARIUS, INC. | TODD STRATEGY GROUP | 3 | $150K | Q1 2023 | Q3 2023 | yes |
| THE COALITION FOR 21ST CENTURY MEDICINE | TODD STRATEGY GROUP | 3 | $150K | Q1 2023 | Q3 2023 | yes |
| BIODESIX, INC. | TODD STRATEGY GROUP | 2 | $60K | Q1 2023 | Q2 2023 | yes |
| BIOTECHNOLOGY INNOVATION ORGANIZATION | TODD STRATEGY GROUP | 2 | $0 | Q1 2023 | Q2 2023 | yes |
| 23ANDME, INC. | W STRATEGIES, LLC | 1 | $20K | Q1 2023 | Q1 2023 | — |
| BRINKS, INC. | JTI MARKETING & COMMUNICATIONS, INC. DBA JTI, INC. | 1 | $0 | Q4 2024 | Q4 2024 | — |
| COALITION FOR INNOVATIVE LABORATORY TESTING, INC. | COMPASS GOVERNMENT RELATIONS PARTNERS, LLC | 1 | $0 | Q1 2023 | Q1 2023 | yes |
| DAVIS BANCORP | JTI MARKETING & COMMUNICATIONS, INC. DBA JTI, INC. | 1 | $0 | Q4 2024 | Q4 2024 | — |
| FIFTH THIRD BANK | JTI MARKETING & COMMUNICATIONS, INC. DBA JTI, INC. | 1 | $0 | Q4 2024 | Q4 2024 | — |
| FOUNDATION MEDICINE, INC. | 1 | $100K | Q1 2023 | Q1 2023 | yes | |
| G+D CURRENCY TECHOLOGY AMERICA, INC. | JTI MARKETING & COMMUNICATIONS, INC. DBA JTI, INC. | 1 | $0 | Q4 2024 | Q4 2024 | — |
| HEALTHCARE INSTITUTE OF NEW JERSEY | 1 | $68K | Q1 2023 | Q1 2023 | yes | |
| LOOMIS ARMORED US | JTI MARKETING & COMMUNICATIONS, INC. DBA JTI, INC. | 1 | $0 | Q4 2024 | Q4 2024 | — |
| LOWERS RISK GROUP | JTI MARKETING & COMMUNICATIONS, INC. DBA JTI, INC. | 1 | $0 | Q4 2024 | Q4 2024 | — |
| MEDICAL DEVICE MANUFACTURERS ASSOCIATION | 1 | $300K | Q1 2023 | Q1 2023 | yes | |
| MYRIAD GENETICS, INC. | TODD STRATEGY GROUP | 1 | $0 | Q1 2023 | Q1 2023 | yes |